76 related articles for article (PubMed ID: 38658552)
1. DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer.
Badalament RA; O'Toole RV; Young DC; Drago JR
Cancer; 1991 Jun; 67(12):3014-23. PubMed ID: 1710533
[TBL] [Abstract][Full Text] [Related]
2. Acquired copy number variation in prostate tumours: a review of common somatic copy number alterations, how they are formed and their clinical utility.
O'Malley DE; Raspin K; Melton PE; Burdon KP; Dickinson JL; FitzGerald LM
Br J Cancer; 2024 Feb; 130(3):347-357. PubMed ID: 37945750
[TBL] [Abstract][Full Text] [Related]
3. High clonal diversity and spatial genetic admixture in early prostate cancer and surrounding normal tissue.
Zhang N; Harbers L; Simonetti M; Diekmann C; Verron Q; Berrino E; Bellomo SE; Longo GMC; Ratz M; Schultz N; Tarish F; Su P; Han B; Wang W; Onorato S; Grassini D; Ballarino R; Giordano S; Yang Q; Sapino A; Frisén J; Alkass K; Druid H; Roukos V; Helleday T; Marchiò C; Bienko M; Crosetto N
Nat Commun; 2024 Apr; 15(1):3475. PubMed ID: 38658552
[TBL] [Abstract][Full Text] [Related]
4. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
[TBL] [Abstract][Full Text] [Related]
5. Significance of abnormal diploid DNA histograms in localized prostate cancer and adjacent benign prostatic tissue.
Deitch AD; Miller GJ; deVere White RW
Cancer; 1993 Sep; 72(5):1692-700. PubMed ID: 7688657
[TBL] [Abstract][Full Text] [Related]
6. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy measured on archived pretreatment biopsy material may correlate with prostate-specific antigen recurrence after prostate brachytherapy.
Keyes M; Macaulay C; Hayes M; Korbelik J; Morris WJ; Palcic B
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):829-34. PubMed ID: 23688814
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of DNA ploidy in carcinoma of prostate.
Dejter SW; Cunningham RE; Noguchi PD; Jones RV; Moul JW; McLeod DG; Lynch JH
Urology; 1989 May; 33(5):361-6. PubMed ID: 2711553
[TBL] [Abstract][Full Text] [Related]
9. scAbsolute: measuring single-cell ploidy and replication status.
Schneider MP; Cullen AE; Pangonyte J; Skelton J; Major H; Van Oudenhove E; Garcia MJ; Chaves Urbano B; Piskorz AM; Brenton JD; Macintyre G; Markowetz F
Genome Biol; 2024 Mar; 25(1):62. PubMed ID: 38438920
[TBL] [Abstract][Full Text] [Related]
10. Archival single-cell genomics reveals persistent subclones during DCIS progression.
Wang K; Kumar T; Wang J; Minussi DC; Sei E; Li J; Tran TM; Thennavan A; Hu M; Casasent AK; Xiao Z; Bai S; Yang L; King LM; Shah V; Kristel P; van der Borden CL; Marks JR; Zhao Y; Zurita AJ; Aparicio A; Chapin B; Ye J; Zhang J; Gibbons DL; ; Sawyer E; Thompson AM; Futreal A; Hwang ES; Wesseling J; Lips EH; Navin NE
Cell; 2023 Aug; 186(18):3968-3982.e15. PubMed ID: 37586362
[TBL] [Abstract][Full Text] [Related]
11. Integration of multiple lineage measurements from the same cell reconstructs parallel tumor evolution.
Kester L; de Barbanson B; Lyubimova A; Chen LT; van der Schrier V; Alemany A; Mooijman D; Peterson-Maduro J; Drost J; de Ridder J; van Oudenaarden A
Cell Genom; 2022 Feb; 2(2):100096. PubMed ID: 36778661
[TBL] [Abstract][Full Text] [Related]
12. MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution.
Kaufmann TL; Petkovic M; Watkins TBK; Colliver EC; Laskina S; Thapa N; Minussi DC; Navin N; Swanton C; Van Loo P; Haase K; Tarabichi M; Schwarz RF
Genome Biol; 2022 Nov; 23(1):241. PubMed ID: 36376909
[TBL] [Abstract][Full Text] [Related]
13. Spatially resolved clonal copy number alterations in benign and malignant tissue.
Erickson A; He M; Berglund E; Marklund M; Mirzazadeh R; Schultz N; Kvastad L; Andersson A; Bergenstråhle L; Bergenstråhle J; Larsson L; Alonso Galicia L; Shamikh A; Basmaci E; Díaz De Ståhl T; Rajakumar T; Doultsinos D; Thrane K; Ji AL; Khavari PA; Tarish F; Tanoglidi A; Maaskola J; Colling R; Mirtti T; Hamdy FC; Woodcock DJ; Helleday T; Mills IG; Lamb AD; Lundeberg J
Nature; 2022 Aug; 608(7922):360-367. PubMed ID: 35948708
[TBL] [Abstract][Full Text] [Related]
14.
Miao C; Tsujino T; Takai T; Gui F; Tsutsumi T; Sztupinszki Z; Wang Z; Azuma H; Szallasi Z; Mouw KW; Zou L; Kibel AS; Jia L
Sci Adv; 2022 Feb; 8(7):eabl9794. PubMed ID: 35179959
[TBL] [Abstract][Full Text] [Related]
15. Somatic Copy Number Alterations in Human Cancers: An Analysis of Publicly Available Data From The Cancer Genome Atlas.
Harbers L; Agostini F; Nicos M; Poddighe D; Bienko M; Crosetto N
Front Oncol; 2021; 11():700568. PubMed ID: 34395272
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
